Nanotechnology News

ERLANGEN, Germany--(BUSINESS WIRE)--LZE GmbH is expanding its technology transfer portfolio and making the RFicient® ultra-low-power wake-up receiver technology from the Fraunhofer Institute for Integrated Circuits IIS available for the first time as a standard chip for close-to-production industrial applications. The solution enables energy-efficient IoT designs that remain continuously reachable while consuming only microamps – a key step for long-lasting, low-maintenance IoT products. LZE Gm...

PITTSBURGH--(BUSINESS WIRE)--RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--HyperLight Corporation, creator of the TFLN Chiplet™  platform, today announced the release of its 145 GHz Packaged Intensity Modulator (IM), expanding the company‘s high-speed modulator portfolio. The new device is designed for ultra-wide modulation bandwidth, high signal fidelity, and stable operation control, enabling 448 Gbps per lane intensity-modulated-direct-detection (IMDD), 260 GBaud coherent links, and broadband RF photonics systems. As symbol rates...

SEATTLE--(BUSINESS WIRE)--Nametag secures two U.S. patents for technology that verifies the human behind enterprise accounts amid rising AI-driven impersonation threats....

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025, and provided a business update. “2025 was an exceptional year for Precision BioSciences marked by meaningful clinical and financial progress. We delivered on what we co...

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that it has invested in Elephantech Inc., a startup developing proprietary nano-ink technology for inkjet printing, and signed a partnership agreement with the company. Through the partnership, Mitsubishi Electric aims to accelerate the industry’s shift to manufacturing printed circuit boards (PCBs) using inkjet printing, a process known for its significantly reduced environmental impact. Previously, Mitsubish...

CAMBRIDGE, Mass. & HSINCHU, Taiwan--(BUSINESS WIRE)--HyperLight Corporation (“HyperLight”), United Microelectronics Corporation (NYSE: UMC; TWSE: 2303)(“UMC”), and Wavetek Microelectronics Corporation (“Wavetek”), a wholly owned subsidiary of UMC, today announced a strategic manufacturing partnership for high-volume foundry production of HyperLight’s TFLN (thin-film lithium niobate) Chiplet™ Platform on both 6-inch and 8-inch wafers. The collaboration marks a major inflection point in the comme...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has received two Notices of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent applications relating to the Company’s PBGENE-HBV program. The first Notice of Allowance relates to U.S. Patent Application No. 19/347,136, tit...

NUREMBERG, Germany & TOKYO--(BUSINESS WIRE)--Renesas announced the general availability of Renesas 365, an intelligent, model-based platform for embedded systems design and lifecycle management....

CANTON, Mass.--(BUSINESS WIRE)--MEDITECH is expanding its Expanse AI portfolio to further improve the clinician experience, empower patients, and maximize financial performance....